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Abstract OBJECTIVE: Semen quality depends on factors such as lifestyle, environment, and 
hormone secretion. Objective: The purpose of the study was to assess the correla-
tion between emotional disorders and the secretion of selected hormones, and to 
assess the impact of these disorders on semen quality. 
METHODS: The study covered 60 fertile and 112 subfertile males. The sperm was 
obtained by masturbation, and examined directly after liquidation according to 
the 2010 criteria of the World Health Organization. The research instruments 
used were: the Beck Depression Inventory (BDI), and the State-Trait Anxiety 
Inventory (STAI). A morning blood sample (5 mL volume) was obtained and 
sent to an authorized laboratory to assess serum levels of testosterone, LH, FSH, 
prolactin, SHBG, DHEA-S and cortisol.
RESULTS: In the group of infertility patients, higher BDI scores were correlated 
with significantly decreased testosterone levels (p=0.001), and increased pro-
lactin and cortisol (p<0.001); statistically significant negative correlations were 
also found between BDI score and SHBG and DHEA-S (p<0.001) levels. Higher 
STAI-1 and STAI-2 in the low-fertility group were associated with higher mean 
prolactin and cortisol levels (p<0.001). Sperm count was shown to be correlated 
with BDI, STAI-1 and STAI-2 scores (p<0.001). Semen volume also correlated 
with BDI, STAI-1 and STAI-2 scores (p<0.001). 
CONCLUSION: Depression and anxiety in subfertile males are associated with 
lower secretion of SHBG and DHEA-S, and higher secretion of cortisol and pro-
lactin. Depression and anxiety in male patients cause decreased semen volume 
and sperm density.
 
INTRODUCTION
Infertility affects nearly one in five couples of 
reproductive age. In many cases, the main cause of 
infertility is decreased semen quality in the male 
partner (Szkodziak et al. 2016). Semen quality 
depend on factors such as lifestyle, environment, 
and sex hormone secretion (Wdowiak et al. 2015; 
Wdowiak et al. 2014). The latter is affected by the 
hypothalamic–pituitary–gonadal axis and by cere-
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bral cortex activity, which can be altered by disorders 
such as depression and anxiety (Bhongade et al. 2015).
Hormone secretion in the testes is controlled by 
pituitary gonadotropins: the luteinizing hormone 
(LH), stimulating sex hormone production by Leydig 
cells, and follicle-stimulating hormone (FSH), which, 
together with testosterone, acts upon seminiferous 
tubules via Sertoli cells to induce and maintain sper-
matogenesis. The release of these two gonadotropins 
from the pituitary gland is controlled by hypothalamic 
decapeptide, gonadotropin releasing hormone (GnRH). 
FSH plays a primary role in hormonal regulation of 
spermatogenesis, but androgen activity independent of 
FSH is also recognized. FSH stimulates division and dif-
ferentiation, inhibits apoptosis of spermatogonia, and 
stimulates meiosis processes, while testosterone con-
trols the course of meiosis, spermatid transformation 
and elongation, and spermatid adhesion to Sertoli cells 
(WHO 2010). Normal release of gonadotropins (FSH 
and LH) occurs with the pulsatile secretion of GnRH. 
A number of factors, including psychogenic ones such 
as stress disrupt the pulse activity of the hypothalamus, 
decreasing gonadotropin levels to a varying extent 
(Tellam et al. 2000).
Some steroid hormones acting as androgens are also 
synthesized in the adrenal cortex. One adrenal andro-
gen is dehydroepiandrosterone sulfate (DHEA-S), 
transformed into dehydroepiandrosterone (DHEA) in 
a range of tissues. The chemical structure of DHEA is 
similar to that of testosterone and other adrogens, to 
which DHEA is an easily transformed precursor (de 
Menezes et al. 2016). The adrenal cortex also produces 
cortisol, and its release is increased by stress. Prolactin 
(PRL) secretion by the pituitary gland is also stimulated 
by stress, and can inhibit the production of FSH and LH 
(Wdowiak et al. 2014). Androgen transport in the body 
is dependent on sex hormone binding globulin (SHBG), 
which is synthesized in the liver and shows high affin-
ity for 17-hydroxysteroid hormones. Hormones bound 
to SHBG are biologically inactive (Handelsman et al. 
2016). The purpose of the study was to assess the cor-
relation between emotional disorders and the secretion 
of selected hormones, and to assess the impact of these 
disorders on semen quality.
MATERIALS AND METHODS
The study was carried out in 2015 and 2016, at the pri-
vately-owned “Ovum” Fertility Clinic in Lublin, Poland. 
The study was approved by the Bioethics Committee of 
the Institute of Rural Health in Lublin (approval no. 
24/2013).
The experimental group included 112 men admit-
ted to the clinic for the first time due to the failure to 
conceive after 12 months of regular unprotected sexual 
intercourse with a regularly ovulating female partner; 60 
confirmed fertile sperm donors were included as con-
trols. Men in both groups were aged between 27 and 33 
years, had a BMI between 18.5 and 24.9, were non-smok-
ers with no history of hazardous alcohol consumption, 
and used no medications. Patients with azoospermia, 
varicocele, and hypogonadotropic hypogonadism 
were excluded from the study. Prior to enrollment, all 
patients signed a written consent form, allowing the 
use of the medical data gathered for research purposes.
Semen was obtained by masturbation, and examined 
directly after liquidation according to the 2010 World 
Health Organization criteria (WHO, 2010). Prior to 
the examination, the patients maintained a 4-day absti-
nence from sex and alcohol. A morning blood sample 
(5 mL volume) was obtained and sent to an authorized 
laboratory to assess serum levels of testosterone, LH, 
FSH, prolactin, SHBG, DHEA-S and cortisol on the 
day of semen collection. The study used two question-
naires: the Beck Depression Inventory (BDI), and the 
State-Trait Anxiety Inventory (STAI). The Beck Depres-
sion Inventory (BDI) is a 21-item scale that enables the 
distinction between healthy individuals and those with 
symptoms of depression, as well as the evaluation of 
depression severity. Responses are rated on a 4-point 
Likert scale and range from 0 (not at all) to 3 (severely). 
The total score for all symptoms, ranging between 0 
and 63 points, is considered an indicator of depression 
severity. For interpretation of study findings, the fol-
lowing cut-off values for depression severity degrees 
were used: 0–11 – no depression, 12–26 – mild depres-
sion, 27–49 – moderate depression, 50–63 – severe 
depression. The resulting Beck Anxiety Inventory 
(BAI) is a 21-item scale that showed high internal con-
sistency (α=0.92) and test–retest reliability over 1 week, 
r (81)=0.75 (Beck et al. 1961; Beck et al. 1988).
The State-Trait Anxiety Inventory (STAI) by C.D. 
Spielberger, R.L. Gorsuch and R.E. Lushene allows the 
evaluation of anxiety as a relatively enduring personality 
trait and as a situation-induced state. The questionnaire 
comprises two scales: STAI-1 is used for investigating 
state anxiety, and STAI-2 – for investigating trait anxi-
ety. Each scale comprises 20 statements. The respon-
dents describe their subjective feelings about each 
statement using a 1–4 scale. Sten results of 1–4 indicate 
low anxiety severity, 5–6 – moderate severity, and 7–10 
– high severity (Sosnowski et al. 2011). Internal con-
sistency coefficients for the scale ranged from 0.86 to 
0.95; test-retest reliability coefficients ranged from 0.65 
to 0.75 over a 2-month interval (Spielberger et al. 1983).
Quantitative parameters were presented using 
means and standard deviations as well as median, mini-
mum and maximum values. Variable distribution in 
the groups studied was tested using the Shapiro-Wilk 
test for normality. Differences between the groups 
were tested using the nonparametric Mann-Whitney 
U-test. Correlations between variables were analyzed 
using Pearson’s r correlation coefficients. Differences or 
correlations at p<0.05 were considered statistically sig-
nificant. The software used for data bases and statistical 
analysis was Statistica 9.1 (StatSoft, Poland).
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RESULTS
The comparison of mean serum levels of selected hor-
mones showed lower mean FSH levels in the experi-
mental group (5.25 IU/L), compared with controls 
(5.63 IU/L, p>0.05). Mean LH levels in the confirmed-
fertile group (5.99 IU/L) were higher than in patients 
treated for fertility disorders (5.53 IU/L), but the dif-
ferences were not significant (p>0.05). Testosterone 
levels were higher in fertile controls (21.03 nmol/L) 
than in patients treated for infertility (13.15 nmol/L; 
Z=–6.813; p<0.001). The sperm donors had signifi-
cantly lower mean PRL levels (16.93 ng/mL) compared 
to the low-fertility patients (25.76 ng/mL; Z=5.10; 
p<0.001). Similar dependence were found for SHBG 
and DHEA-S. In controls, mean SHBG levels were 
higher (142.60 nmol/L) than in the experimental group 
(77.29 nmol/L), and the difference was statistically 
significant (Z=–6.608; p<0.001). The mean DHEA-S 
concentration in fertile men was 161.28 mg/mL, and 
in the low-fertility patients – 94.24 mg/mL (Z=–6.14; 
p<0.001). In the experimental group, the mean cor-
tisol level was 165.35 μg/dL, and in controls it was 
130.78 μg/dL (Z=5.965; p<0.001) (Table 1).
In the confirmed-fertile group, the mean sperm 
count was 57.84 M/mL and was significantly higher 
than in the group treated for infertility, where the mean 
value was 35.46 M/mL (Z=–5.529; p<0.001). The mean 
ejaculate volume was also higher in the sperm donors 
(5.56 ml) than in the infertility patients (3.38 ml) 
(Z=–6.077; p<0.001). Differences between the two 
groups in terms of other semen parameters were not 
statistically significant (p>0.05) (Table 2).
The infertile patients had higher mean BDI scores 
than the sperm donors: 18.69 vs. 5.27 (p<0.001). The 
mean state anxiety (STAI-1) score in the experimental 
group was 6.05, while in the controls it was 2.15, and 
the difference was statistically significant (p<0.001). 
Tab. 1. Hormone levels in the two groups.
Hormones
Experimental group Control group
Z p-value
Mean ± SD Median Range Mean ± SD Median Range
FSH [IU/l] 5.25±3.83 4.51 0.55–15.78 5.63±1.75 5.51 1.78–9.97 –2.187 0.029
LH [IU/l] 5.53±3.91 4.67 0.77–16.56 5.99±2.47 5.90 1.59–18.55 –1.703 0.089
Testosterone [nmol/l] 13.15±6.51 12.00 5–31 21.03±5.78 22.00 9–31 –6.814 <0.001
Prolactin [ng/ml] 25.76±10.61 25.00 8.5–42.8 16.93±6.58 16.40 8.2–33.5 5.105 <0.001
SHBG [nmol/l] 77.29±55.26 52.00 18–170 142.6±16.97 145.00 100–171 –6.608 <0.001
DHEA-S [mg/ml] 94.24±74.83 84.00 25–351 161.28±79.29 130.00 78–390 –6.145 <0.001
Cortisol [μg/dL] 165.35±38.69 160.00 105–237 130.78±24.67 121.00 105–210 5.965 <0.001
Tab. 2. Comparison of semen quality between confirmed-fertile and infertile men.
Semen 
characteristics
Experimental group Control group
Z p–value
Mean ± SD Median Range Mean ± SD Median Range
Sperm count [mln/ml] 35.46±23.66 24.00 8–118 57.84±21.59 51.00 32–132 –5.530 <0.001
Progresive motility [%] 51.79±7.67 53.86 25.18–62.91 49.64±8.63 51.36 25.18–62.73 1.603 0.109
Viability [%] 75.7±12.9 79.00 29–91 74.77±14.84 78.00 29–91 0.153 0.878
Normal morpholgy  [%] 8.84±4.43 9.00 1–19 9.77±5.18 11.00 1–19 –1.330 0.184
Semen volume [ml] 3.38±1.97 3.00 0.5–9.5 5.57±2 5.50 1.5–9.5 –6.077 <0.001
MAR test IgG [%] 7.46±14.42 0.00 0–95 5.62±7.01 5.00 0–35 –0.081 0.935
MAR test IgA [%] 10.87±15.81 5.00 0–98 9.1±9.59 7.00 0–40 –0.023 0.982
Tab. 3. The mean BDI, STAI-1, and STAI-2 scores in the two groups.
Scale
Experimental group Control group
Z p–value
Mean ± SD Median Range Mean ± SD Median Range
BDI 18.69±15.62 11.00 0.5–9.5 5.27±1.92 5.00 1.5–9.5 7.882 <0.001
STAI-1 6.05±2.68 7.00 29–91 2.15±0.95 2.00 29–91 8.263 <0.001
STAI-2 5.79±2.92 6.50 25.18–62.91 1.50±0.68 1.00 25.18–62.73 8.578 <0.001
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A similar distribution of scores was obtained for trait 
anxiety (STAI-2): the mean score for infertility patients 
was 5.79, while for sperm donors it was 1.50 (p<0.001) 
(Table 3). 
In the experimental group, higher BDI scores were 
associated with significantly decreased testosterone 
(r=–0.322; p<0.001), increased prolactin (r=0.562; 
p<0.001), and increased cortisol levels (r=0.657; 
p<0.001). Statistical analysis also showed significant 
negative correlations between BDI score and SHBG 
(r=–0.712; p<0.001) and DHEA-S levels (r=–0.588; 
p<0.001) in the group. No significant correlations were 
found for FSH and LH (p>0.05). In the confirmed-
fertile group there were no statistically significant cor-
relations between BDI scores and the mean levels of the 
hormones studied (p>0.05). Our analyses showed that 
higher STAI-1 scores in the infertility patient group 
were associated with higher mean prolactin (r=0.598; 
p<0.001) and cortisol levels (r=0.697; p<0.001), and 
with lower SHBG (r=–0.843, p<0.001) and DHEA-S 
levels (r=–0.766, p<0.001). No significant correlations 
were found between STAI-1 and FSH, LH, or testoster-
one (p>0.05). In the confirmed-fertile group there were 
no statistically significant correlations between STAI-1 
scores and the hormones studied (p>0.05). In the low-
fertility group, higher STAI-2 scores were correlated 
with lower SHBG (r=–0.858; p<0.001) and DHEA-S 
levels (r=–0.732; p<0.001). The study also showed a 
positive correlation between STAI-2 scores and prolac-
tin (r=0.639; p<0.001) and cortisol (r=0.665; p<0.001). 
No statistically significant correlations were found 
between STAI-2 and FSH, LH, or testosterone in the 
experimental group (p>0.05). In the control group, the 
only positive significant correlation was found between 
STAI-2 and LH (r=0.354; p<0.01) (Table 4).
In the low-fertility group, statistically significant 
negative correlations were found between sperm count 
and scores in the BDI (r=–0.496; p<0.001) (Figure 1), 
STAI-1 (r=–0.665; p<0.001) (Figure 2), and STAI-2 
(r=–0.645; p<0.001) (Figure 3). 
Ejaculate volume was negative correlated with BDI 
(r=–0.484; p<0.001) (Figure 4), STAI-1 (r=–0.568; 
p<0.001) (Figure 5), and STAI-2 (r=–0.656; p<0.001) 
(Figure 6) in the infertility patient group.
In the low-fertility group higher percentages of 
sperm with progressive motility were associated with 
lower STAI-1 (r=–0.239; p<0.05) and STAI-2 scores 
Tab. 4. Correlations between BDI, STAI-1, and STAI-2 scores and mean hormone levels in the experimental group and in the controls.
Hormones
BDI STAI-1 STAI-2
Experimental 
group
Control 
group
Experimental 
group
Control 
group
Experimental 
group
Control 
group
FSH 
[IU/l]
–0.046 –0.141 –0.044 –0.224 –0.061 0.151
p=0.631 p=0.286 p=0.645 p=0.085 p=0.523 p=0.252
LH 
[IU/l]
0.031 –0.079 0.007 –0.081 0.033 0.354
p=0.752 p=0.548 p=0.941 p=0.537 p=0.729 p<0.01
Testosterone 
[nmol/l]
–0.322 –0.007 –0.048 –0.019 –0.074 0.013
p<0.001 p=0.958 p=0.612 p=0.882 p=0.443 p=0.924
Prolactin 
[ng/ml]
0.562 –0.045 0.598 0.167 0.639 –0.173
p<0.001 p=0.734 p<0.001 p=0.201 p<0.001 p=0.187
SHBG
[nmol/l]
–0.712 0.115 –0.843 –0.013 –0.858 0.021
p<0.001 p=0.381 p<0.001 p=0.917 p<0.001 p=0.873
DHEA-S
[mg/ml]
–0.588 0.268 –0.766 –0.074 –0.732 0.142
p=0.000 p=0.039 p<0.001 p=0.573 p<0.001 p=0.279
Cortisol
[μg/dL]
0.657 –0.036 0.697 0.162 0.665 –0.031
p<0.001 p=0.787 p<0.001 p=0.215 p<0.001 p=0.818
 r = -0.496, p<0.001
0 20 40 60 80 100 120 140
sperm count [mln/ml]
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D
I
Fig. 1. Correlation between BDI scores and sperm count in the 
experimental group.
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(r=–0.255; p<0.01). In this group, there were also weak 
correlations between sperm morphology and scores in 
the BDI (r=–0.256; p<0.01), STAI-1 (r=–0.224; p<0.01), 
and STAI-2 (r=–0.253; p<0.01) scales. No statistically 
significant correlations were found in the experimen-
tal group between BDI scores, and sperm motility, 
vitality, IgG-MAR, or IgA-MAR (p>0.05). Similarly, 
neither STAI-1 nor STAI-2 were significant correlated 
with sperm vitality, IgG-MAR, or IgA-MAR (p>0.05) 
in this group. In the confirmed-fertile group, no cor-
relation was found between the depression and anxiety 
scales and any semen characteristics analyzed (p>0.05) 
(Table 5).
DISCUSSION
Literature on the subject of male infertility becomes 
more extensive every year. It provides a wealth of 
information on infertility, including its causes, treat-
ment, and social and psychological aspects (Newson 
et al. 2007; Drosdzol & Skrzypulec 2009; Gollenberg et 
al. 2010; Wichman et al. 2011; Fisher & Hammarberg 
 r = -0.665, p<0.001
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Fig. 2. Correlation between STAI-1 scores and sperm count in the 
experimental group.
Fig. 3. Correlation between STAI-2 scores and sperm count in the 
experimental group.
Fig. 4. Correlation between BDI scores and ejaculate volume in the 
experimental group.
Fig. 5. Correlation between STAI-1 scores and ejaculate volume in 
the experimental group.
 r = -0.656, p<0.001
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Fig. 6. Correlation between STAI-2 scores and ejaculate volume in 
the experimental group.
2012; Wdowiak et al. 2017). The purpose of the study 
was to assess the correlation between emotional dis-
orders and the secretion of selected hormones, and to 
assess the impact of these disorders on semen quality 
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in men treated for infertility. Study findings showed 
that men with fertility problems are more likely to have 
emotional disorders than fertile sperm donors. In the 
patients, more severe depressive symptoms (BDI: 18.69 
vs. 5.277), state anxiety (STAI-1: 6.05 vs. 2.15), and trait 
anxiety (STAI-2: 5.79 vs. 1.50) were found. Analyses 
of the results showed that the mean BDI in the experi-
mental group indicated mild depression, while mean 
STAI scores indicated moderate anxiety. These find-
ings are in line with those reported by Drozdzol and 
Skrzypulec, and Wichman et al. (Drosdzol & Skrzypu-
lec 2009; Wichman et al. 2011). A study by Volgsten et 
al. including 545 couples treated for infertility showed 
that approximately 30% of infertile women and 10% of 
infertile men fulfilled the diagnostic criteria for depres-
sion and/or anxiety disorders, including subthreshold 
diagnoses (Volgsten et al. 2008). Furthermore, a study 
by Tüzer et al. indicated that depressive symptoms in 
men predicted increased anxiety during infertility treat-
ment (Tüzer et al. 2010). One should consider that stress 
levels in infertile patients tend to increase as treatment 
continues, in proportion to time in treatment, meaning 
that the mean severity of depression and anxiety can 
increase (Gollenberg et al. 2010; Fisher & Hammar-
berg 2012). This may be due e.g. to repeated treatment 
procedures (such as semen collection), fertility treat-
ment costs, or the male patients’ awareness of being the 
one with the fertility problem (Tüzer et al. 2010). On 
the other hand, Wichman et al.’s analysis of the clini-
cal indicators of mental health in infertile and healthy 
men showed no significant differences between the two 
groups. However, the impact of a range of factors on 
infertile men’s psychological state should be empha-
sized. Men with a tendency towards social isolation, 
with an avoidance coping style, and perceiving stressful 
events as overwhelming, are more likely to experience 
severe anxiety than those without these traits (Wich-
man et al. 2011).
Increased emotional tension or emotional distur-
bance associated with infertility diagnostics and treat-
ment can interfere with normal functioning of the body. 
The present study of interaction between depression 
and anxiety disorders on the one hand, and hormone 
secretion on the other, showed higher depression sever-
ity to be correlated with lower testosterone, SHGB, 
and DHEA-S levels, and with increased prolactin and 
cortisol levels. No similar association with FSH or LH 
was found. Meanwhile, Bak et al. in their study of men 
with nonobstructive azoospermia (NOA), reported a 
positive correlation between FSH and LH and anxiety, 
in contrast to testosterone, which was inversely associ-
ated with anxiety (Bak et al. 2012). Similar results were 
obtained by Bhongade et al. who investigated the impact 
of psychological stress on male sex hormones. Men with 
a higher severity of anxiety and depression had higher 
serum levels of FSH and LH than those without similar 
disorders (Bhongade et al. 2015). 
Abnormal testosterone levels can impair the mecha-
nisms of spermatogenesis and spermiogenesis. Fur-
thermore, low testosterone concentration is a marker 
of HPA activation. One factor that can dysregulate tes-
tosterone secretion is chronic anxiety and depression 
(Lieberman et al. 2016). In the present study, higher 
depression severity was associated with lower testoster-
one. This is not, however, corroborated by Ponholzer et 
al.’s study, where testosterone levels were not correlated 
with depression or its severity (Ponholzer et al. 2009). 
By testing for total testosterone and SHBG levels it is 
possible to determine the bioavailability of testosterone. 
Increased SHBG levels indicate that the concentration 
of unbound testosterone available to tissues is lower 
than can be expected based on the total testosterone 
level. In turn, decreased SHBG suggests a higher bio-
availability of testosterone (Handelsman et al. 2016; Li 
et al. 2016). In the present study, the mean SHBG level 
was inversely associated with mean depression sever-
Tab. 5. Correlations between BDI, STAI-1, and STAI-2 scores and semen characteristics in the experimental group and in the controls.
Hormones
BDI STAI-1 STAI-2
Experimental 
group
Control 
group
Experimental 
group
Control 
group
Experimental 
group
Control 
group
Progresive motility 
[%]
–0.162 0.125 –0.239 –0.112 –0.255 0.084
p=0.088 p=0.340 p<0.05 p=0.397 p<0.01 p=0.523
Viability
[%]
–0.161 0.078 –0.152 –0.149 –0.124 0.063
p=0.090 p=0.555 p=0.109 p=0.256 p=0.194 p=0.632
Normal morpholgy 
[%]
–0.256 –0.067 –0.224 –0.029 –0.253 –0.201
p<0.01 p=0.611 p<0.01 p=0.822 p<0.01 p=0.125
MAR test
IgG [%]
0.169 –0.009 0.173 0.072 0.119 0.119
p=0.075 p=0.940 p=0.069 p=0.584 p=0.213 p=0.364
MAR test
IgA [%]
0.142 –0.034 0.171 0.016 0.108 0.209
p=0.134 p=0.798 p=0.071 p=0.902 p=0.259 p=0.109
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ity (BDI) and anxiety (STAI-1 and STAI-2) scores in 
the infertility patient group only. The available litera-
ture includes no reports on correlations between SHBG 
levels and emotional disorders.
The present study showed an association between 
increased prolactin levels and higher severity of depres-
sion and anxiety. Available literature reports regarding 
the role of PRL secretion in emotional disorders are 
equivocal, both for humans and for animal models. 
Animal studies by Torner et al. demonstrated that 
exogenous PRL administration has an anxiolytic effect 
in rats of both sexes (Torner et al. 2001). Long-term 
prolactin administration in ovariectomized female rats 
used to simulate the endocrine status of pregnancy 
was shown to decrease anxiety (Donner et al. 2007). 
Meanwhile, another study involving rodents showed an 
association between high prolactin levels and increased 
anxiety. Increased basal and stress-induced levels of 
PRL were reported in male rats bred for high-anxiety 
behavior as compared to low-anxiety behavior rats 
(Landgraf et al. 1999). Similarly conflicting results are 
reported in human models. On the one hand, patients 
with hyperprolactinemia report more anxiety and hos-
tility than controls (Reavley et al. 1997). On the other 
hand, experiments by Reavley et al. and by Oliveira et 
al. found no differences in terms of depression between 
patients with hyperprolactinemia and controls (Reav-
ley et al. 1997; Oliveira et al. 2000). Literature on the 
subject does not include studies directly investigating 
the association between emotional disorders and pro-
lactin secretion in male patients treated for infertility. 
Existing reports regarding animal and human models 
without reference to fertility disorders point to a need 
for further investigation of this area in the light of the 
present findings. DHEA-S is a marker of stress that per-
sists longer after secretion than cortisol and plays a role 
in modulating the body’s susceptibility to the negative 
effects of stress (Morgan et al. 2004). In the experimen-
tal group, negative correlations were found between 
DHEA-S levels and mean depression, state anxiety, and 
trait anxiety scores. This is corroborated by Maninger et 
al. and Mocking et al. reporting an association between 
depression and low DHEA-S levels, especially when 
related to high cortisol, though the authors emphasize 
that the findings are not conclusive (Maninger et al. 
2009; Mocking et al. 2015).
Cortisol is a biological marker of hypothalamic–
pituitary–adrenal (HPA) axis activation in humans. 
It also shows complex associations with depressive 
disorders (Morgan et al. 2004; Mocking et al. 2015). 
Bhongade et al. Ogawa et al. and Slade et al. analyzing 
stress levels in men treated for infertility, showed it to 
be higher than in healthy men (Bhongade et al. 2015; 
Ogawa et al. 2011; Slade et al. (2007). In men, stress 
adversely affects semen quality and can inhibit GnRH 
secretion through hypothalamic–pituitary axis activa-
tion (Tellam et al. 2000; Pantalone & Faiman 2012). 
Stress-induced spermatogenesis impairment is typically 
manifested in decreased sperm count and motility, and 
an increased percentage of morphologically abnormal 
sperm. Importantly, hormonal imbalances depend on 
the strength and type of stressor, the time the stressor is 
active, and the initial state of the patient.
The present analysis showed high BDI, STAI-1, and 
STAI-2 scores to be correlated with high cortisol levels. 
Disorders affecting the hypothalamic–pituitary–adre-
nal (HPA) axis, glucocorticoids such as cortisol, and 
pituitary proopiomelanocortin derivatives induced by 
the corticotropin-releasing hormone (CRH) inhibit 
hypothalamic–pituitary–gonadal axis control. The 
adverse impact of stress on the reproductive function 
might also be due to an increased level of tumor necro-
sis factor (TNF) and an increased number of natural 
killer (NK) cells (Cwikel et al. 2004). An increase in 
stress hormone levels, i.e. cortisol and adrenocortico-
tropic hormone (ACTH), can impair androstenedione 
to testosterone conversion in Leydig cells. This dis-
rupts the hormonal transformation cycle required for 
testosterone secretion, leading to lower average values 
of semen volume and sperm density (Gollenberg et al. 
2010; Klimek et al. 2005). Moreover, acute or chronic 
stress in men can activate the HPA, as demonstrated by 
increased levels of the catabolic hormone cortisol and 
suppressed release of the anabolic hormone testoster-
one (Lieberman et al. 2016).
The present study demonstrated that correlations 
between scores in the STAI and BDI scales and the hor-
mone levels and semen characteristics analyzed are only 
statistically significant in the group of men treated for 
infertility, and not in the confirmed-fertile group. It is 
likely that this is due to the fact that the fertile controls 
were less affected by emotional disorders. The negative 
correlation between BDI scores and testosterone levels 
in the infertility patient group can be related to the 
lower sperm density and semen volume resulting from 
spermatogenesis dysfunction induced by depression 
(which affects the hypothalamic–pituitary–gonadal 
axis). The impact of sex hormone secretion on repro-
ductive dysfunction has been confirmed in a number 
of studies, including Wdowiak et al. Tellam et al. and 
Pantalone and Faiman (Wdowiak et al. 2014; Tellam et 
al. 2000; Pantalone & Faiman 2012). 
The present results corroborate the report by 
Bhongade et al. who administered the Hospital Anxi-
ety and Depression Score (HADS) questionnaire to 70 
men treated for infertility, and compared the results 
to sex hormone levels and semen parameters. The 
patients were divided into two groups: those with 
normal HADS (<8) and those with increased HADS 
(diagnosed with emotional disturbance). Patients with 
emotional disturbance were found by Bhongade et al. to 
have lower testosterone levels and sperm density. Based 
on the correlation between HADS and sperm density, 
the authors found that higher HADS is associated with 
lower sperm density and motility and higher percent-
age of morphologically abnormal sperm, which is cor-
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roborated by the present study (Bhongade et al. 2015). 
Somewhat different findings were reported by Gürhan 
et al. who investigated associations between depression 
(BDI) and anxiety (STAI), and sperm count and motil-
ity, among other factors. The authors found no correla-
tion between men’s emotional disorders and the semen 
characteristics studied (Gürhan et al. 2009). 
Zorn et al.’s regression analyses indicated a signifi-
cant positive correlation between the sperm concentra-
tion and the WHO Well-Being Index score; successive 
correlations were found between psychological factors 
and sperm’s rapid progressive motility and normal mor-
phology (Zorn et al. 2008). With regard to sperm den-
sity, these results are in line with those of the present 
study and those reported by Bhongade et al. but they 
differ with regard to sperm motility and morphology 
(Zorn et al. 2008; Bhongade et al. 2015). Eskiocak et 
al. explained the sperm quality decrease from stress-
ors by referring to the decrease in glutathione and free 
sulphydryl in seminal plasma (Eskiocak et al. 2005). 
These authors investigated the impact of psychologi-
cal stress (assessed using the STAI questionnaire) on 
seminal glutathione and free sulphydryl content and 
sperm quality. Two semen samples were collected from 
each of 34 healthy volunteers: one under stress, and one 
in the absence of stressors. The analysis demonstrated 
that under stress, the motility index of spermatozoa was 
significantly lower, whereas the percentage of morpho-
logically abnormal spermatozoa was higher than during 
the non-stress period. An association between seminal 
plasma glutathione and motility index was observed at 
both periods. These results confirm the impact of stress 
on sperm density, in line with the present findings and 
those reported by other authors (Eskiocak et al. 2005; 
Zorn et al. 2008; Bhongade et al. 2015). Gollenberg et 
al. note that the experience of two or more stressful life 
events is associated with decreased sperm density and 
the percentage of motile sperm, as well as an increased 
likelihood of testing below normal ranges for concen-
tration, motility, and morphology. However, as empha-
sized by the authors, further studies should investigate 
whether the elimination of stressful life events could 
effect an increase in semen quality, and whether the 
adverse impact of stress is lasting or temporary (Gol-
lenberg et al. 2010).
Postmeiotic germ cells grow in an immune-privi-
leged site, thanks to the barrier formed by Sertoli cell 
tight junctions. If the “blood–testis barrier” is breached, 
antibodies are formed against spermatozoa. Conditions 
resulting in damage to the blood–testis barrier and 
antisperm antibody formation include testis trauma, 
toxicity, inflammation and infection (Niederberger, 
2011). Antibody levels determined in both groups in 
the present study were not correlated with the partici-
pants’ emotional state. The available literature also lacks 
reports associating antibody levels in the semen with 
emotional disorders. However, the report on IgG, IgM, 
and IgA antibodies in blood serum of women by Kian-
bakth et al. indicates that IgG secretion is decreased in 
depressive patients (Kianbakth et al. 2013). A similar 
finding was reported by Goldm et al. regarding IgA 
antibodies, whose secretion was decreased in depres-
sive patients, while IgG and IgM levels were not associ-
ated with emotional disorders (Gold et al. 2012). The 
issue of immune response and emotional disorders will 
undoubtedly require further investigation.
The present study demonstrated that depression and 
anxiety disorders can disrupt hormonal balance and 
adversely affect semen quality. They can also have a 
negative impact on infertility treatment outcomes, thus 
warranting the development of management guidelines 
for cases of emotional disorders in the course of such 
treatment. The psychological background of infertility 
is difficult to diagnose by a physician, requiring collab-
oration with other specialists: psychiatrists, psycholo-
gists, psychotherapists. On the other hand, Fisher and 
Hammarberg report that men with fertility problems 
prefer to receive emotional support from infertility cli-
nicians rather than from mental health professionals, 
self-help support groups or friends (Fisher & Hammar-
berg 2012).
CONCLUSIONS
• Men treated for infertility are found to have more 
severe depression and anxiety than those confirmed 
to be fertile.
• Depressive disorders in men treated for infertility 
contribute to decreased testosterone levels.
• Depression and anxiety in low-fertility male patients 
are associated with lower secretion of SHBG and 
DHEA-S, and higher secretion of cortisol and 
prolactin.
• Depression and anxiety in male patients cause 
decreased semen volume and sperm density.
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